分娩鎮痛の有効性と安全性に対する超音波リアルタイム誘導技術の効果
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Fujian
-
Fuzhou、Fujian、中国、350001
- Fujian Provincial Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
包含基準:
- 米国麻酔科医協会 (ASA) クラス I または II。
- 単一の健康な妊娠。
- 頭が最初に表示されます。
- 37~41週間。
- 陣痛は活発で、子宮口は 5cm 未満に開いています。
- 硬膜外分娩鎮痛が必要です。
- この研究に自発的に参加し、インフォームドコンセントフォームに署名してください。
除外基準:
- 妊娠高血圧症、子癇前症、妊娠糖尿病などの妊娠疾患の存在。
- 脊髄内鎮痛に対する禁忌: 1) 中枢神経系疾患。 2) 穿刺部位の感染または敗血症。 3) 凝固機能障害。
- 子宮破裂の病歴など、胎児奇形または帝王切開のリスク増加の既知の症例。
- 精神疾患、ヒステリー、てんかんなどの既往歴があり、協力ができない方。
- オピオイド、ステロイドの長期使用、慢性疼痛のある患者。
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:硬膜穿刺硬膜外グループと組み合わせた超音波リアルタイム ガイダンス
超音波リアルタイムガイダンスと硬膜穿刺硬膜外治療を組み合わせることで、分娩鎮痛の臨床効果を向上させることができます。
|
超音波リアルタイムガイダンス技術は、操作の視覚化による椎間腔位置決めの精度、成功率、穿刺損傷の軽減の点で、従来のブラインド探査技術に比べて大きな利点があり、脊椎ブロックの有効性と安全性を大幅に向上させます。
|
|
アクティブコンパレータ:硬膜穿刺硬膜外グループ
硬膜穿刺硬膜外穿刺は、脊髄硬膜外併用療法を臨床的に改良したもので、母体に広く使用されています。
実施手順は、硬膜外穿刺を完了し、一時的にチューブを留置せず、くも膜下麻酔針で硬膜を穿刺しますが、くも膜下腔に直接薬剤を注入せず、硬膜外ブロックに従って投与するために硬膜外カテーテルを残します。 。
|
硬膜穿刺硬膜外穿刺は、脊髄硬膜外併用療法を臨床的に改良したもので、母体に広く使用されています。
実施手順は、硬膜外穿刺を完了し、一時的にチューブを留置せず、くも膜下麻酔針で硬膜を穿刺しますが、くも膜下腔に直接薬剤を注入せず、硬膜外ブロックに従って投与するために硬膜外カテーテルを残します。 。
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Composite endpoint of labor analgesia outcome
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
The primary outcome is a binary composite endpoint: "satisfactory" (Grades I-II) versus "unsatisfactory" (Grades III-IV). Grading followed a hierarchical rule (IV > III > II > I): if more than one grade applied, the highest (worst) was assigned. Grade I (best): vaginal delivery (spontaneous or instrumental) with analgesic onset ≤ 20 min, mean VAS ≤ 40 mm, no catheter or protocol adjustment, and modified Bromage score < 2. Grade II (good): vaginal delivery not meeting Grade I criteria but with onset ≤ 30 min, mean VAS ≤ 60 mm, and no Grade IV-listed complications. Grade III (poor): cesarean delivery, or onset > 30 min, or mean VAS > 60 mm. Grade IV (worst): serious analgesia-related complications (unintended dural puncture with the epidural needle, Bromage score ≥ 2, persistent neurological injury, local anesthetic toxicity, or severe hypotension requiring intervention). |
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Time to analgesia onset
時間枠:Within 30 minutes after initial drug administration.
|
Time from initial drug administration to the first documented Visual Analogue Scale (VAS) score ≤ 30 mm.
VAS scale: 0 = no pain, 100 mm = worst possible pain.
|
Within 30 minutes after initial drug administration.
|
|
Visual Analogue Scale (VAS) score
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Time-weighted mean pain VAS score from analgesia start to delivery, derived from area under the curve (AUC) calculation.
VAS scale: 0 = no pain, 100 mm = worst possible pain.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Number of patient-controlled analgesia (PCA) demands
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Number of PCA bolus demands during labor analgesia.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Local anesthetic consumption
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Per-minute local anesthetic consumption during labor analgesia.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Sensory blockade level
時間枠:During the labor analgesia period (assessed up to 24 hours).
|
Sensory blockade level assessed by loss of cold sensation using an alcohol swab, recorded at 30 min after the loading dose and at the highest level.
|
During the labor analgesia period (assessed up to 24 hours).
|
|
Incidence of asymmetric block
時間枠:During the labor analgesia period (assessed up to 24 hours).
|
Defined as a ≥ 2-dermatome difference in sensory blockade level between the left and right sides.
|
During the labor analgesia period (assessed up to 24 hours).
|
|
Sensory blockade at the second sacral dermatome (S2)
時間枠:During the labor analgesia period (assessed up to 24 hours).
|
S2 sensory blockade categorized as bilateral, unilateral, or none.
|
During the labor analgesia period (assessed up to 24 hours).
|
|
Number of Participants with Physician Interventions
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Physician interventions including analgesic regimen adjustments, epidural catheter repositioning, and re-puncture.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Modified Bromage score
時間枠:During the labor analgesia period (assessed up to 24 hours).
|
Motor blockade assessed by the modified Bromage score: 0 = full flexion of knees and ankles, 1 = partial flexion of knees with full flexion of ankles, 2 = inability to flex knees with partial flexion of ankles, 3 = inability to flex knees and ankles.
|
During the labor analgesia period (assessed up to 24 hours).
|
|
Side effects of labor analgesia
時間枠:From analgesia initiation until delivery and postpartum (assessed up to 72 hours).
|
Incidence of lower limb numbness (defined as loss of cold sensation by alcohol swab test), urinary retention (defined as inability to void spontaneously within 8 h postpartum requiring catheterization), nausea and vomiting, and postpartum headache.
|
From analgesia initiation until delivery and postpartum (assessed up to 72 hours).
|
|
Cesarean delivery rate and indications
時間枠:At delivery.
|
Rate of cesarean delivery and indications for cesarean delivery (non-reassuring fetal heart rate, arrest of descent, maternal indications, other).
|
At delivery.
|
|
Mean uterine contraction frequency
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Time-weighted mean uterine contraction frequency, derived from area under the curve (AUC) calculation from analgesia to delivery.
Unit of measure: contractions per 10 minutes
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Mean single uterine contraction duration
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Time-weighted mean single uterine contraction duration, derived from area under the curve (AUC) calculation from analgesia to delivery.
Unit of measure: seconds.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Incidence of uterine hypertonia
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Defined as a single contraction lasting > 2 min.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Incidence of uterine tachysystole
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Defined as > 5 contractions per 10 min.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Duration of each stage of labor
時間枠:From labor onset to delivery of the placenta (assessed up to 24 hours).
|
Duration of the first, second, third, and total stages of labor.
|
From labor onset to delivery of the placenta (assessed up to 24 hours).
|
|
Maternal body temperature
時間枠:Pre-analgesia and at delivery.
|
Maternal body temperature before analgesia and at delivery.
|
Pre-analgesia and at delivery.
|
|
NICHD fetal heart rate tracing classification
時間枠:From the baseline assessment (pre-analgesia) through delivery (assessed up to 24 hours).
|
NICHD (National Institute of Child Health and Human Development) Fetal Heart Tracing Classification: Category I (normal), Category II (indeterminate), Category III (abnormal).
A higher category indicates a less reassuring fetal status.
|
From the baseline assessment (pre-analgesia) through delivery (assessed up to 24 hours).
|
|
NICHD category progression rate
時間枠:From baseline (pre-analgesia) through delivery (assessed up to 24 hours).
|
Proportion of parturients whose NICHD category worsened from baseline during labor analgesia.
|
From baseline (pre-analgesia) through delivery (assessed up to 24 hours).
|
|
Fetal heart rate
時間枠:From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
Time-weighted mean fetal heart rate from analgesia to delivery, derived from area under the curve (AUC) calculation.
|
From initiation of labor analgesia to delivery (assessed up to 24 hours).
|
|
Fetal heart rate decelerations
時間枠:From the baseline assessment (pre-analgesia) through delivery (assessed up to 24 hours).
|
Types of fetal heart rate decelerations (early, late, variable).
|
From the baseline assessment (pre-analgesia) through delivery (assessed up to 24 hours).
|
|
Fetal heart rate variability
時間枠:From the baseline assessment (pre-analgesia) through delivery (assessed up to 24 hours).
|
Fetal heart rate variability categorized as absent, minimal, moderate, or marked.
|
From the baseline assessment (pre-analgesia) through delivery (assessed up to 24 hours).
|
|
Neonatal Apgar scores
時間枠:At 1, 5, and 10 minutes after birth.
|
Apgar scores assessed at 1, 5, and 10 minutes after birth.
The Apgar score ranges from 0 to 10, with higher scores indicating better condition.
The proportion of neonates with Apgar < 7 at 1 minute is also reported.
|
At 1, 5, and 10 minutes after birth.
|
|
Post-delivery hs-CRP level
時間枠:Pre-delivery (baseline, within 1 week before delivery) and 30 minutes after delivery.
|
Post-delivery hs-CRP level in venous blood, adjusted for pre-delivery baseline value using analysis of covariance (ANCOVA).
Unit of measure: mg/L.
|
Pre-delivery (baseline, within 1 week before delivery) and 30 minutes after delivery.
|
|
Post-delivery IL-6 level
時間枠:Pre-delivery (baseline, within 1 week before delivery) and 30 minutes after delivery.
|
Post-delivery IL-6 level in venous blood, adjusted for pre-delivery baseline value using analysis of covariance (ANCOVA).
Unit of measure: pg/mL.
|
Pre-delivery (baseline, within 1 week before delivery) and 30 minutes after delivery.
|
|
Post-delivery cortisol level
時間枠:Pre-delivery (baseline, within 1 week before delivery) and 30 minutes after delivery.
|
Post-delivery cortisol level in venous blood, adjusted for pre-delivery baseline value using analysis of covariance (ANCOVA).
Unit of measure: nmol/L.
|
Pre-delivery (baseline, within 1 week before delivery) and 30 minutes after delivery.
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Zongxun Lin, Master、Fujian Provincial Hospital
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。